Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification

International Journal of Pharmaceutics

Volumn 184, Issue 1, 1999, Pages 97-105

  Lamprecht, A ^a,b   Ubrich, N ^a   Hombreiro Perez M ^a   Lehr, C M ^b   Hoffman, M ^a   Maincent, P ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Bovin serum albumin; Encapsulation; Nanoparticles; Poly caprolactone ; Poly lactic co glycolic acid ; w o w emulsion

Indexed keywords

BOVINE SERUM ALBUMIN; NANOPARTICLE; POLYCAPROLACTONE; POLYGLACTIN; POLYMER; POLYVINYL ALCOHOL; PROTEIN; SURFACTANT;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIODEGRADATION; CONTROLLED STUDY; DISPERSION; DISSOLUTION; DRUG RELEASE; EMULSION; MICROENCAPSULATION; MODEL; PARTICLE SIZE; PRESSURE; PRIORITY JOURNAL; SURFACE PROPERTY; TECHNIQUE; ZETA POTENTIAL;

BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; EMULSIONS; LACTIC ACID; PARTICLE SIZE; POLYESTERS; POLYGLYCOLIC ACID; POLYMERS; POLYVINYL ALCOHOL; SERUM ALBUMIN, BOVINE; SOLUBILITY; SURFACE PROPERTIES;

EID: 0033032891     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00107-6     Document Type: Article

References (23)

1. Alex R., Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. J. Microencapsulation. 7:1989;347-355.
2. Alyautdin R.N., Petrov V.E., Langer K., Berthold A., Kharkevich D.A., Kreuter J. Delivery of loperamide across the blood brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm. Res. 14:1997;325-328.
3. Armstrong T.I., Davies M.C., Illum L. Human serum albumin as a probe for protein adsorption to nanoparticles. J. Drug Target. 4:1997;389-398.
4. Arshady R. Preparation of biodegradable microspheres and microcapsules: 2. polylactides and related polyesters. J. Control. Release. 17:1991;1-22.
5. Blanco M.D., Alonso M.J. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur. J. Pharm. Biopharm. 43:1997;287-294.
6. Bodmeier R., McGinity J.W. Solvent selection in the preparation of poly (DL-lactide) microspheres prepared by the solvent evaporation method. Int. J. Pharm. 43:1988;179-186.
7. Bourel D., Rolland A., Le Verge R., Genetet B. A new immunoreagent for cell labeling CD3 monoclonal antibody covalently coupled to fluorescent polymethacrylic nanoparticles. J. Immunol. Methods. 106:1988;161-167.
8. Iwata M., McGinity J.W. Preparation of multi-phase microspheres of poly(lactic acid) and poly(lactic-co-glycolic acid) containing a W/O emulsion by a multiple solvent evaporation technique. J. Microencapsulation. 9:1992;201-214.
9. Jalil R., Nixon J.R. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsulation. 7:1990;297-325.
10. Jeffery H., Davis S.S., O'Hagan D.T. The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 10:1993;362-368.
11. Kreuter J. Colloidal Drug Delivery Systems. Drugs and the Pharmaceutical Sciences. 66:1994;Marcel Dekker, New York.
12. Lemoine D., Préat V. Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J. Control. Release. 54:1998;15-27.
13. Maincent P., Thouvenot P., Amicabile C., Hoffman M., Kreuter J., Couvreur P., Devissaguet J.P. Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats. Pharm. Res. 9:1992;1534-1539.
14. Nakada Y., Fattal E., Foulquier M., Couvreur P. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. Pharm. Res. 13:1996;38-43.
15. Nihant N., Schugens C., Grandfils C., Jérôme R., Teyssié P. Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability. Pharm. Res. 11:1994;1479-1484.
16. Niwa T., Takeuchi H., Hina T., Nohara M., Kawashima Y. Biodegradable submicron carriers for peptide drugs: preparation of DL-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system. Int. J. Pharm. 121:1995;45-54.
17. Ogawa Y., Yamamoto M., Okada H., Yashiki T., Shimamoto T. A new technique to efficiently entrap leuprolide acetate in microcapsules of copoly(lactic/glycolic acid). Chem. Pharm. Bull. 36:1988;1095-1103.
18. Peterson P.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:1977;346-356.
19. Schugens C., Laruelle N., Nihant N., Grandfils C., Jérôme R., Teyssié P. Effect of the emulsion stability on the morphology and porosity of semicristalline poly L-lactide microparticles prepared by w/o/w double emulsion-evaporation. J. Control. Release. 32:1994;161-176.
20. Tabata Y., Takebayashi Y., Ueda T., Ikada Y. A formulation method using D,L-lactic acid oligomer for protein released with reduced initial burst. J. Control. Release. 23:1993;55-64.
21. Tobío M., Gref R., Sánchez A., Langer R., Alonso M.J. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm. Res. 15:1998;270-275.
22. Velge-Roussel F., Breton P., Guillon X., Lescure F., Bout D., Hoebeke J. Immunochemical characterization of antibody-coated nanoparticles. Experientia. 52:1996;803-806.
23. Verrachia T., Spenlehauer G., Bazile D.V., Murry-Brelier A., Archimbaud Y., Veillard M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drugs carriers. J. Control. Release. 36:1995;49-61.